Breaking News Instant updates and real-time market news.

AOS

A.O. Smith

$47.51

-0.58 (-1.21%)

08:58
11/06/18
11/06
08:58
11/06/18
08:58

A.O. Smith remains a long-term growth opportunity, says Baird

Baird analyst Michael Halloran said he remains a buyer of A.O. Smith shares as he continues to believe organic 2021 earnings power will grow. When combined with its premium financial profile and net-cash positive balance sheet, the current valuation represents an attractive entry point, said Halloran, who reiterated his Outperform rating and $54 price target on A.O. Smith.

AOS A.O. Smith
$47.51

-0.58 (-1.21%)

10/02/18
GSCO
10/02/18
INITIATION
Target $50
GSCO
Sell
A.O. Smith initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Doug Clark started A.O. Smith with a Sell rating and $50 price target. The analyst rolled out coverage on the Building Products sector with Neutral rating.
10/02/18
GSCO
10/02/18
INITIATION
Target $50
GSCO
Sell
A.O. Smith initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Doug Clark initiated A.O. Smith with a Sell and $50 price target based on expectations for volume declines in its core US water heater business and its exposure to China.
10/10/18
BARD
10/10/18
NO CHANGE
Target $58
BARD
Outperform
A.O. Smith weakness a buying opportunity, says Baird
Baird analyst Michael Halloran said A.O. Smith shares have been under pressure and near-term trading is likely to remain challenging. The analyst said the pressure is driven by weaker China growth, North American residential cycle concerns, and the prospect for a lower longer-term growth rate. He said the shares are approaching an attractive entry point, but investors should be patient as near-term risks are likely to drive short-term underperformance. Halloran maintained his Outperform rating but lowered his price target to $58 from $68 on A.O. Smith shares.
10/31/18
BMOC
10/31/18
NO CHANGE
Target $66
BMOC
Outperform
A.O. Smith price target lowered to $66 from $73 at BMO Capital
BMO Capital analyst R. Scott Graham lowered his price target on A.O. Smith to $66 after its Q3 earnings miss and a cut in FY18 guidance reflecting "disappointing" North America sales and a lower than expected initial organic sales growth outlook for 2019. The analyst also lowered his FY18 EPS view to $2.57 from $2.63 but kept his Outperform rating, stating that the recent decline in the company's stock price has exceeded his revisions.

TODAY'S FREE FLY STORIES

MATW

Matthews

$43.21

2.91 (7.22%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Recommendations
Matthews analyst commentary  »

Matthews price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
HSBC to hold a conference »

China Healthcare…

QURE

uniQure

$31.89

0.89 (2.87%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
uniQure to host research and development day »

Research &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CFX

Colfax

$28.00

0.31 (1.12%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
Colfax to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

UMRX

Unum Therapeutics

$8.07

0.1 (1.25%)

08:25
11/19/18
11/19
08:25
11/19/18
08:25
Conference/Events
Unum Therapeutics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 01

    Dec

ADIL

Adial Pharmaceuticals

$1.28

-0.05 (-3.76%)

08:24
11/19/18
11/19
08:24
11/19/18
08:24
Hot Stocks
Adial Pharmaceuticals engages Crown CRO to begin Phase 3 trial for AD04 »

Adial Pharmaceuticals and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:23
11/19/18
11/19
08:23
11/19/18
08:23
Conference/Events
Daiwa to hold a conference »

Asia Communication Days…

VICI

VICI Properties

$21.29

0.16 (0.76%)

08:22
11/19/18
11/19
08:22
11/19/18
08:22
Initiation
VICI Properties initiated  »

VICI Properties initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$190.74

-0.05 (-0.03%)

08:20
11/19/18
11/19
08:20
11/19/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$68.22

-0.1 (-0.15%)

08:19
11/19/18
11/19
08:19
11/19/18
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$67.23

0.76 (1.14%)

08:19
11/19/18
11/19
08:19
11/19/18
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$388.18

2.67 (0.69%)

08:19
11/19/18
11/19
08:19
11/19/18
08:19
Hot Stocks
Equinix to build new flagship data center in London »

Equinix announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

  • 10

    Dec

XLY

Consumer Discretionary Sector SPDR

$106.37

-0.43 (-0.40%)

08:19
11/19/18
11/19
08:19
11/19/18
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$55.23

0.53 (0.97%)

08:18
11/19/18
11/19
08:18
11/19/18
08:18
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.86

0.77 (1.42%)

08:18
11/19/18
11/19
08:18
11/19/18
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$56.04

0.15 (0.27%)

08:18
11/19/18
11/19
08:18
11/19/18
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$92.05

0.91 (1.00%)

08:18
11/19/18
11/19
08:18
11/19/18
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$151.96

0.33 (0.22%)

08:17
11/19/18
11/19
08:17
11/19/18
08:17
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$254.05

0.67 (0.26%)

08:17
11/19/18
11/19
08:17
11/19/18
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RILY

B. Riley Financial

$17.65

-0.14 (-0.79%)

, FBIO

Fortress Biotech

$1.24

0.08 (6.90%)

08:17
11/19/18
11/19
08:17
11/19/18
08:17
Hot Stocks
B. Riley Financial to buy majority National Holdings stake for $3.25 per share »

B. Riley Financial (RILY)…

RILY

B. Riley Financial

$17.65

-0.14 (-0.79%)

FBIO

Fortress Biotech

$1.24

0.08 (6.90%)

NHLD

National Holdings Corp

$2.96

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$273.75

0.91 (0.33%)

08:17
11/19/18
11/19
08:17
11/19/18
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

08:17
11/19/18
11/19
08:17
11/19/18
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.